Korea Arlico Pharm Co.,Ltd. (KOSDAQ:260660)

Korea Arlico Pharm Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 22, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	62,458	52,955	87,364	100,392	117,712	142,830
Market Cap Growth	14.79%	-39.39%	-12.98%	-14.71%	-17.59%	3.78%
Enterprise Value	94,998	83,746	102,863	93,513	100,409	140,080
Last Close Price	4075.00	3397.16	5483.79	6160.30	7081.66	8436.77
PE Ratio	-	-	28.54	12.50	23.88	17.06
PS Ratio	0.30	0.28	0.47	0.60	0.84	1.14
PB Ratio	0.79	0.67	0.98	1.13	1.45	1.84
P/TBV Ratio	0.86	0.73	1.07	1.23	1.53	1.95
P/FCF Ratio	-	-	-	-	31.82	-
P/OCF Ratio	34.65	-	12.22	20.76	13.13	31.42
EV/Sales Ratio	0.46	0.44	0.55	0.56	0.72	1.12
EV/EBITDA Ratio	12.86	57.52	13.11	7.21	13.57	11.09
EV/EBIT Ratio	46.69	-	33.48	9.48	20.94	13.22
EV/FCF Ratio	-201.15	-	-	-	27.14	-
Debt / Equity Ratio	0.65	0.63	0.52	0.35	0.16	0.13
Debt / EBITDA Ratio	6.92	34.65	5.90	2.40	1.70	0.77
Debt / FCF Ratio	-	-	-	-	3.41	-
Asset Turnover	1.21	1.10	1.15	1.22	1.21	1.09
Inventory Turnover	2.95	3.05	2.84	2.58	2.72	2.87
Quick Ratio	0.68	0.66	0.76	0.91	1.43	1.44
Current Ratio	1.16	1.14	1.19	1.43	2.04	2.15
Return on Equity (ROE)	-1.69%	-6.35%	3.45%	9.47%	6.21%	11.25%
Return on Assets (ROA)	0.75%	-1.86%	1.17%	4.49%	2.59%	5.79%
Return on Invested Capital (ROIC)	1.81%	-4.79%	2.82%	12.39%	6.35%	14.41%
Return on Capital Employed (ROCE)	2.10%	-5.30%	3.00%	10.20%	5.50%	12.70%
Earnings Yield	-2.19%	-10.12%	3.50%	8.00%	4.19%	5.86%
FCF Yield	-0.76%	-22.82%	-18.58%	-14.08%	3.14%	-3.39%
Payout Ratio	-	-	63.76%	13.08%	19.43%	22.89%
Buyback Yield / Dilution	0.14%	48.99%	-94.89%	-0.18%	0.06%	-51.13%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.